Costs · nurses working on acute care, intensive care or medical care units
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 30 days · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
All‐cause mortality at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Number of participants with Variceal rebleeding episodes at 30 days · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with Variceal rebleeding episodes at 30 days compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Reintervention Number of women with reintervention · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with reintervention at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Irreversible shunt occlusion at 5 years · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes irreversible shunt occlusion at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Encephalopathy · people with cirrhotic portal hypertension
It is very uncertain whether surgical portosystemic shunts changes number of participants with encephalopathy at 5 years compared with transjugular intrahepatic portosystemic shunt (TIPS) (very low certainty).
1 finding from 1 review
Health‐related quality of life · people with cirrhotic portal hypertension
1 finding from 1 review
Time to initiation of antimicrobial therapy (Time to initiation starts at the time of admission) · people admitted to intensive care units
It is very uncertain whether automated monitoring systems changes time to initiation of antimicrobial therapy (Time to initiation… compared with standard care (very low certainty).
1 finding from 1 review
Time to initiation of fluid resuscitation (Time to initiation starts at the time of admission) · people admitted to intensive care units
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
30‐day mortality* · people admitted to intensive care units
It is very uncertain whether automated monitoring systems changes 30‐day mortality* compared with standard care (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Duration of ICU stay · people admitted to intensive care units
1 finding from 1 review
Failed detection of sepsis (as reported by studies) · people admitted to intensive care units
1 finding from 1 review
Quality of life measured at the latest available time point post‐discharge from ICU (preferred measure SF‐36 then EQ‐5D) · people admitted to intensive care units
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · patients with hypertension
Enalapril plus folic acid leads to lower stroke compared with enalapril (high certainty).
1 finding from 1 review
First unstable angina pectoris episode requiring hospitalisation · patients with hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause · patients with hypertension
Enalapril plus folic acid showed no clear difference in death from any cause compared with enalapril (high certainty).
1 finding from 1 review
Serious adverse event (cancer) · patients with hypertension
Enalapril plus folic acid showed no clear difference in serious adverse event (cancer) compared with enalapril (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with hypertension
Enalapril plus folic acid showed no clear difference in myocardial infarction compared with enalapril (moderate certainty).
1 finding from 1 review
Intervention not reported
Systolic blood pressure clinical digital sphygmomanometer · adults with or without hypertension
1 finding from 1 review